LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-09-08
Case ID: NM_001126049.2_c.-535_-534insC_20260908_171953
Framework: ACMG/AMP 2015
Variant classification summary

NM_001126049.2:c.-535_-534insC

KLLN  · NP_001119521.1:p.?  · NM_001126049.2
GRCh37: chr10:89622778 A>AG  ·  GRCh38: chr10:87863021 A>AG
Gene: KLLN Transcript: NM_001126049.2
Final call
VUS
PM2 supporting BP4 supporting
All criteria require review: For research and educational purposes only.
Gene
KLLN
Transcript
NM_001126049.2
Protein
NP_001119521.1:p.?
gnomAD AF
ClinVar
OncoKB
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): the 5' untranslated region insertion is absent from gnomAD v2.1, v4.1, and gnomAD-Canada v1.0 population reference datasets.
2
BP4 (Supporting): SpliceAI maximum delta score 0.022 is below the 0.1 threshold, predicting no significant splice impact.
3
Overall classification: VUS - the conflicting PM2 (supporting) and BP4 (supporting) evidence meets no ACMG/AMP 2015 Pathogenic or Benign combination threshold.
Final determination: Under the generic ACMG/AMP 2015 fallback, PM2 supporting plus BP4 supporting is a conflicting one-supporting-pathogenic/one-supporting-benign combination that defaults to VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: the insertion lies in the 5' untranslated region upstream of the coding sequence, leaving the encoded protein unchanged.
pvs1_variant_assessment
PS1 N/A Not applicable: this is a noncoding 5' insertion with no amino-acid change (p.(=)), so there is no missense to compare with known pathogenic changes.
PS2 Not assessed Not assessed: no de novo occurrence with confirmed maternity/paternity and absence of the variant in both parents is documented.
PS3 Not assessed Not assessed: no validated functional assay result for this specific insertion was available.
PS4 Not assessed Not assessed: no case series, case-control comparison, or enrichment statistic for this exact insertion was available.
PM1 N/A Not applicable: the variant is upstream of the coding sequence, so no amino-acid residue exists to evaluate against functional domains or hotspots.
PM2 Met Met (supporting): the variant is absent from gnomAD v2.1, gnomAD v4.1, and gnomAD-Canada v1.0 population reference datasets.
gnomad_v2 gnomad_v4 gnomad_canada
PM3 Not assessed Not assessed: no affected-proband observations, phase data, or co-occurring pathogenic alleles were identified.
PM4 N/A Not applicable: the 5' untranslated region insertion leaves the protein unchanged (p.(=)) and does not alter protein length.
pvs1_variant_assessment
PM5 N/A Not applicable: not a missense variant, so there is no amino-acid residue at which an alternate pathogenic missense could be compared.
PM6 Not assessed Not assessed: no suspected de novo occurrence without confirmed parental testing is documented.
PP1 Not assessed Not assessed: no affected relatives, familial genotypes, or phenotype-segregation data were identified.
PP2 N/A Not applicable: intended for missense variants in genes where missense is a common disease mechanism; this is a noncoding insertion.
PP3 Not met Not met: SpliceAI maximum delta 0.022 does not exceed the >0.2 PP3 threshold.
spliceai generic_acmg_combination_rules
PP4 Not assessed Not assessed: no phenotype or clinical information for the carrier was provided, so phenotype specificity cannot be evaluated.
PP5 Not met Not met: the exact variant is absent from ClinVar, so no expert-panel pathogenic assertion exists to support it.
clinvar
BA1 Not met Not met: the variant is absent from population databases, so no allele frequency exceeds the stand-alone benign threshold.
gnomad_v2 gnomad_v4 gnomad_canada
BS1 Not met Not met: the variant is absent from population datasets, so no allele frequency exceeds the benign threshold for the relevant disorder.
gnomad_v2 gnomad_v4 gnomad_canada
BS2 Not assessed Not assessed: no unaffected adult carriers or unaffected homozygotes with phenotype information were identified.
BS3 Not assessed Not assessed: no validated functional study demonstrating a normal effect of this variant was available.
BS4 Not assessed Not assessed: no variant-carrying family members or informative non-segregation observations were documented.
BP1 N/A Not applicable: intended for missense variants in genes where truncation is the established mechanism; this is a noncoding insertion.
BP2 Not assessed Not assessed: no phase observations or co-occurring pathogenic variants were identified to establish a trans/cis relationship.
BP3 N/A Not applicable: applies to in-frame coding indels in repeat regions; this 5' insertion leaves the protein unchanged (p.(=)).
pvs1_variant_assessment
BP4 Met Met (supporting): SpliceAI maximum delta 0.022 falls below the 0.1 BP4 threshold, predicting no significant splice impact.
spliceai generic_acmg_combination_rules
BP5 Not assessed Not assessed: no alternative causal diagnosis was documented to determine whether another finding explains the phenotype.
BP6 Not met Not met: the exact variant is absent from ClinVar, so no expert-panel benign assertion exists to support it.
clinvar
BP7 N/A Not applicable: reserved for synonymous coding variants; this is a 5' untranslated region insertion, not a synonymous change.
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.